Stoke Therapeutics Inc buy Wedbush
Start price
17.03.26
/
50%
€28.60
Target price
17.03.27
€33.05
Performance (%)
-11.33%
Price
17.07.26
€25.36
Summary
This prediction is currently active. The price of Stoke Therapeutics Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.33%. This prediction currently runs until 17.03.27. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | - | - |
| iShares Core DAX® | 0,85 % | 0,39 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % |
| iShares S&P 500 | 0,06 % | 0,78 % |
Comments by Wedbush for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics (STOK) had its price target raised by Wedbush from $36.00 to $38.00. They now have an "outperform" rating on the stock.
Ratings data for STOK provided by MarketBeat
Stopped prediction by Wedbush for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€23.60
12.01.26
12.01.26
€30.88
12.01.27
12.01.27
7.46%
17.07.26
17.07.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€19.00
05.11.25
05.11.25
€27.84
05.11.26
05.11.26
33.47%
17.07.26
17.07.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€13.60
13.08.25
13.08.25
€18.84
13.08.26
13.08.26
86.47%
17.07.26
17.07.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€13.00
11.07.24
11.07.24
€15.62
11.07.25
11.07.25
-23.46%
12.07.25
12.07.25
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€9.30
26.03.24
26.03.24
€15.67
26.03.25
26.03.25
-27.42%
27.03.25
27.03.25